Sanara MedTech Inc. (SMTI)

Sanara MedTech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-4.89	-4.3	-7.94	-7.92	-4.36	-2.81
Depreciation & Amortization	4.37	4.02	2.63	0.77	0.41	0.22
Share-Based Compensation	3.65	3.44	2.7	2.67	1.4	0
Other Operating Activities	-6.23	-6.4	-2.95	-0.33	-1.49	0.43
Operating Cash Flow	-3.1	-3.25	-5.55	-4.81	-4.03	-2.17
Capital Expenditures	-0.3	-0.26	-0.15	-0.17	-0.54	-0.18
Acquisitions	-9.94	-9.94	-2.52	0	0	0.51
Change in Investments	0	0	-0.25	-4.53	-1.1	0
Other Investing Activities	-	-	-0.6	-0.58	-1.1	-1.52
Investing Cash Flow	-10.25	-10.21	-3.51	-5.28	-2.74	-1.2
Share Issuance / Repurchase	0.1	0.78	-0.41	28.5	0.04	10
Debt Issued / Paid	8.79	8.87	0	0	0.58	0
Other Financing Activities	-	-	-0.22	-0.2	-	-0.2
Financing Cash Flow	8.89	9.64	-0.63	28.3	0.62	9.8
Net Cash Flow	-4.46	-3.81	-9.69	18.2	-6.16	6.44
Free Cash Flow	-3.4	-3.51	-5.7	-4.99	-4.58	-2.35
Free Cash Flow Margin	-5.00%	-5.40%	-12.43%	-20.65%	-29.38%	-19.97%
Free Cash Flow Per Share	-0.40	-0.42	-0.72	-0.68	-0.80	-1.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).